Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (1-10 of 503) with videos related to

Pageof 51
Sort By:
Blood|July 13, 2019
Quest of biomarkers for venetoclax-treated CLLDavide Rossi
Hematological Oncology|June 19, 2013
IX. Chronic lymphocytic leukaemia: new genetic markers as prognostic factorsDavide Rossi
Leukemia & Lymphoma|August 18, 2012
Richter syndrome and fludarabine: a controversial relationshipDavide Rossi
Hematology. American Society of Hematology. Education Program|February 20, 2015
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesisDavide Rossi
Hematological Oncology|June 11, 2015
XIII. Molecular pathogenesis of transformed lymphomasDavide Rossi
Leukemia & Lymphoma|June 6, 2013
Inherited susceptibility to chronic lymphocytic leukemia: the good candidatesDavide Rossi
Blood|February 23, 2019
<i>FBXW7</i> is a biologically validated cancer driver gene for CLLDavide Rossi
Best Practice & Research. Clinical Haematology|October 16, 2016
Richter's syndrome: Novel and promising therapeutic alternativesDavide Rossi
Blood|February 15, 2014
SAMHD1: a new gene for CLLDavide Rossi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2025
Assessing Remission in Diffuse Large B-Cell Lymphoma: Will Minimal Residual Disease Add Value to Positron Emission Tomography?Davide Rossi
Pageof 51

Showing results (1-10 of 503) with videos related to

Sort By:
Pageof 51
Blood|July 13, 2019
Quest of biomarkers for venetoclax-treated CLLDavide Rossi
Hematological Oncology|June 19, 2013
IX. Chronic lymphocytic leukaemia: new genetic markers as prognostic factorsDavide Rossi
Leukemia & Lymphoma|August 18, 2012
Richter syndrome and fludarabine: a controversial relationshipDavide Rossi
Hematology. American Society of Hematology. Education Program|February 20, 2015
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesisDavide Rossi
Hematological Oncology|June 11, 2015
XIII. Molecular pathogenesis of transformed lymphomasDavide Rossi
Leukemia & Lymphoma|June 6, 2013
Inherited susceptibility to chronic lymphocytic leukemia: the good candidatesDavide Rossi
Blood|February 23, 2019
<i>FBXW7</i> is a biologically validated cancer driver gene for CLLDavide Rossi
Best Practice & Research. Clinical Haematology|October 16, 2016
Richter's syndrome: Novel and promising therapeutic alternativesDavide Rossi
Blood|February 15, 2014
SAMHD1: a new gene for CLLDavide Rossi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2025
Assessing Remission in Diffuse Large B-Cell Lymphoma: Will Minimal Residual Disease Add Value to Positron Emission Tomography?Davide Rossi
Pageof 51